Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-22

Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial updating Avastin (bevacizumab) combined with chemotherapy in Chinese patients with metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED